Corporate Information And Statement Of Ifrs Compliance [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183077

Concept 2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification
Domicile of entity
Rue Saint-Georges 5, 4000 Liège
Legal form of entity
Country of incorporation
Belgium
Statement of IFRS compliance [text block]
Basis of presentation
Disclosure of uncertainties of entity's ability to continue as going concern [text block]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories
50,312,000 EUR
43,852,000 EUR
Disclosure of objectives, policies and processes for managing capital [text block]

Talk to a Data Expert

Have a question? We'll get back to you promptly.